Evidence map›Paper›PMID 33163714›Full record

ArticleKidney international reports2020

A Multicenter Randomized Clinical Trial of Hemodialysis Access Blood Flow Surveillance Compared to Standard of Care: The Hemodialysis Access Surveillance Evaluation (HASE) Study.

Loay Salman, Abid Rizvi, Gabriel Contreras, Christina Manning, Paul J Feustel, Ivy Machado, Patricia L Briones, Aamir Jamal, Nicolle Bateman, Laisel Martinez and 3 more

Abstract read
In one paragraph

Article in Kidney international reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Loay SalmanAlbany Medical College, Albany, New York, USA.
Abid RizviCalifornia Kidney Specialists, San Dimas, California, USA.
Gabriel ContrerasUniversity of Miami Miller School of Medicine, Miami, Florida, USA.
Christina ManningAlbany Medical College, Albany, New York, USA.
Paul J FeustelAlbany Medical College, Albany, New York, USA.
Ivy MachadoUniversity of Miami Miller School of Medicine, Miami, Florida, USA.
Patricia L BrionesUniversity of Miami School of Nursing, Miami, Florida, USA.
Aamir JamalCalifornia Kidney Specialists, San Dimas, California, USA.
Nicolle BatemanDialysis Clinic Inc., Albany, New York, USA.
Laisel MartinezUniversity of Miami Miller School of Medicine, Miami, Florida, USA.
Marwan TabbaraUniversity of Miami Miller School of Medicine, Miami, Florida, USA.
Roberto I Vazquez-PadronUniversity of Miami Miller School of Medicine, Miami, Florida, USA.
Arif AsifJersey Shore University Medical Center, Hackensack-Meridian School of Medicine at Seton Hall University, Neptune, New Jersey, USA.

Funding

Cellular Mechanisms of Mac-1 Mediated AtheroprotectionK08HL151747 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MARTINEZ, LAISEL · 2020 to 2024
$575k
NHLBI NIH HHS K08 HL151747
6 · The paper itself

Abstract

introductionArteriovenous (AV) access thrombosis remains 1 of the most troubling AV access-related complications affecting hemodialysis patients. It necessitates an urgent and occasionally complicated thrombectomy procedure and increases the risk of AV access loss. AV access stenosis is found in the majority of thrombosed AV accesses. The routine use of AV access surveillance for the early detection and management of stenosis to reduce the thrombosis rate remains controversial.

methodsWe have conducted a multicenter, prospective, randomized clinical trial comparing the standard of care coupled with ultrasound dilution technique (UDT) flow measurement monthly surveillance with the standard of care alone.

resultsWe prospectively randomized 436 patients with end-stage renal disease on hemodialysis with arteriovenous fistula (AVF) or arteriovenous graft (AVG) using cluster (shift) randomization to surveillance and control groups. There were no significant differences in the baseline demographic data between the 2 groups, except for ethnicity (

conclusionThe use of UDT flow measurement monthly AV access surveillance in this multicenter randomized controlled trial reduced the per-patient thrombotic events without significantly increasing the total number of angiographic procedures. Even though there is a trend, surveillance did not reduce the first thrombotic event rate.

Indexed as

arteriovenous access blood flowarteriovenous access thrombosisarteriovenous fistulaarteriovenous grafthemodialysis access surveillanceultrasound dilution technique

Identifiers

PMID33163714
PMCPMC7609971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.